---
title: "Lepu Medical: The first subject has been dosed in the Phase II clinical trial of MWN105 injection"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255908536.md"
description: "According to the Zhitong Finance APP, Lepu Medical announced that its holding subsidiary Shanghai Minwei Biotechnology Co., Ltd. (referred to as \"Minwei Biotechnology\") has independently developed the innovative drug MWN105 injection, which is currently conducting a Phase II clinical trial for the treatment of overweight or obesity, and has recently successfully completed the administration for the first subject"
datetime: "2025-09-04T08:17:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255908536.md)
  - [en](https://longbridge.com/en/news/255908536.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255908536.md)
generator: "portal-rs"
---

# Lepu Medical: The first subject has been dosed in the Phase II clinical trial of MWN105 injection

According to the Zhitong Finance APP, Lepu Medical (300003.SZ) announced that its holding subsidiary Shanghai Minwei Biotechnology Co., Ltd. (referred to as "Minwei Biotechnology") has independently developed the innovative drug MWN105 injection, which is currently conducting a Phase II clinical trial for the treatment of overweight or obesity, and has recently successfully completed the administration for the first subject

### Related Stocks

- [300003.CN](https://longbridge.com/en/quote/300003.CN.md)

## Related News & Research

- [Flexdeal chair Alberto Amaral buys EUR 150,000 in shares](https://longbridge.com/en/news/296250174.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)
- [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md)
- [Helport AI expands revenue-generating AI Labor deployments for consumer hardware customer service in North America, Europe](https://longbridge.com/en/news/296491820.md)
- [Invo Fertility highlights retrospective IVF platelet-rich plasma studies at Midwest Reproductive Symposium 2026](https://longbridge.com/en/news/296495699.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**